208 related articles for article (PubMed ID: 17020882)
1. Heparan sulfate proteoglycans (HSPGs) modulate BMP2 osteogenic bioactivity in C2C12 cells.
Jiao X; Billings PC; O'Connell MP; Kaplan FS; Shore EM; Glaser DL
J Biol Chem; 2007 Jan; 282(2):1080-6. PubMed ID: 17020882
[TBL] [Abstract][Full Text] [Related]
2. Heparan sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage differentiation.
Fisher MC; Li Y; Seghatoleslami MR; Dealy CN; Kosher RA
Matrix Biol; 2006 Jan; 25(1):27-39. PubMed ID: 16226436
[TBL] [Abstract][Full Text] [Related]
3. Changes in secreted and cell associated proteoglycan synthesis during conversion of myoblasts to osteoblasts in response to bone morphogenetic protein-2: role of decorin in cell response to BMP-2.
Gutierrez J; Osses N; Brandan E
J Cell Physiol; 2006 Jan; 206(1):58-67. PubMed ID: 15920756
[TBL] [Abstract][Full Text] [Related]
4. A novel regulatory role for stromal-derived factor-1 signaling in bone morphogenic protein-2 osteogenic differentiation of mesenchymal C2C12 cells.
Zhu W; Boachie-Adjei O; Rawlins BA; Frenkel B; Boskey AL; Ivashkiv LB; Blobel CP
J Biol Chem; 2007 Jun; 282(26):18676-85. PubMed ID: 17439946
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of Nell-1 and BMP-2 on the osteogenic differentiation of myoblasts.
Cowan CM; Jiang X; Hsu T; Soo C; Zhang B; Wang JZ; Kuroda S; Wu B; Zhang Z; Zhang X; Ting K
J Bone Miner Res; 2007 Jun; 22(6):918-30. PubMed ID: 17352654
[TBL] [Abstract][Full Text] [Related]
6. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor.
Kanzaki S; Takahashi T; Kanno T; Ariyoshi W; Shinmyouzu K; Tujisawa T; Nishihara T
J Cell Physiol; 2008 Sep; 216(3):844-50. PubMed ID: 18449905
[TBL] [Abstract][Full Text] [Related]
7. Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts.
Nakashima A; Katagiri T; Tamura M
J Biol Chem; 2005 Nov; 280(45):37660-8. PubMed ID: 16150699
[TBL] [Abstract][Full Text] [Related]
8. Interaction of Tmem119 and the bone morphogenetic protein pathway in the commitment of myoblastic into osteoblastic cells.
Tanaka K; Inoue Y; Hendy GN; Canaff L; Katagiri T; Kitazawa R; Komori T; Sugimoto T; Seino S; Kaji H
Bone; 2012 Jul; 51(1):158-67. PubMed ID: 22579779
[TBL] [Abstract][Full Text] [Related]
9. Low-level laser irradiation enhances BMP-induced osteoblast differentiation by stimulating the BMP/Smad signaling pathway.
Hirata S; Kitamura C; Fukushima H; Nakamichi I; Abiko Y; Terashita M; Jimi E
J Cell Biochem; 2010 Dec; 111(6):1445-52. PubMed ID: 20830741
[TBL] [Abstract][Full Text] [Related]
10. Disruption of heparan and chondroitin sulfate signaling enhances mesenchymal stem cell-derived osteogenic differentiation via bone morphogenetic protein signaling pathways.
Manton KJ; Leong DF; Cool SM; Nurcombe V
Stem Cells; 2007 Nov; 25(11):2845-54. PubMed ID: 17702986
[TBL] [Abstract][Full Text] [Related]
11. Heparan sulfate is required for bone morphogenetic protein-7 signaling.
Irie A; Habuchi H; Kimata K; Sanai Y
Biochem Biophys Res Commun; 2003 Sep; 308(4):858-65. PubMed ID: 12927798
[TBL] [Abstract][Full Text] [Related]
12. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model.
Zhu W; Rawlins BA; Boachie-Adjei O; Myers ER; Arimizu J; Choi E; Lieberman JR; Crystal RG; Hidaka C
J Bone Miner Res; 2004 Dec; 19(12):2021-32. PubMed ID: 15537446
[TBL] [Abstract][Full Text] [Related]
13. C2C12 myoblast/osteoblast transdifferentiation steps enhanced by epigenetic inhibition of BMP2 endocytosis.
Rauch C; Brunet AC; Deleule J; Farge E
Am J Physiol Cell Physiol; 2002 Jul; 283(1):C235-43. PubMed ID: 12055092
[TBL] [Abstract][Full Text] [Related]
14. Neurogenesin-1 differentially inhibits the osteoblastic differentiation by bone morphogenetic proteins in C2C12 cells.
Chandra A; Itakura T; Yang Z; Tamakoshi T; Xue X; Wang B; Ueki T; Sato K; Uezato T; Miura N
Biochem Biophys Res Commun; 2006 Jun; 344(3):786-91. PubMed ID: 16630536
[TBL] [Abstract][Full Text] [Related]
15. 'Two-stage double-technique hybrid (TSDTH)' identification strategy for the analysis of BMP2-induced transdifferentiation of premyoblast C2C12 cells to osteoblast.
Kim BG; Lee JH; Ahn JM; Park SK; Cho JH; Hwang D; Yoo JS; Yates JR; Ryoo HM; Cho JY
J Proteome Res; 2009 Oct; 8(10):4441-54. PubMed ID: 19655815
[TBL] [Abstract][Full Text] [Related]
16. Heparan sulfate proteoglycans mediate the angiogenic activity of the vascular endothelial growth factor receptor-2 agonist gremlin.
Chiodelli P; Mitola S; Ravelli C; Oreste P; Rusnati M; Presta M
Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):e116-27. PubMed ID: 21921258
[TBL] [Abstract][Full Text] [Related]
17. Amelogenin binds to both heparan sulfate and bone morphogenetic protein 2 and pharmacologically suppresses the effect of noggin.
Saito K; Konishi I; Nishiguchi M; Hoshino T; Fujiwara T
Bone; 2008 Aug; 43(2):371-376. PubMed ID: 18515207
[TBL] [Abstract][Full Text] [Related]
18. Activated beta-catenin induces osteoblast differentiation of C3H10T1/2 cells and participates in BMP2 mediated signal transduction.
Bain G; Müller T; Wang X; Papkoff J
Biochem Biophys Res Commun; 2003 Jan; 301(1):84-91. PubMed ID: 12535644
[TBL] [Abstract][Full Text] [Related]
19. Isolation of a native osteoblast matrix with a specific affinity for BMP2.
Grünert M; Dombrowski C; Sadasivam M; Manton K; Cool SM; Nurcombe V
J Mol Histol; 2007 Oct; 38(5):393-404. PubMed ID: 17682830
[TBL] [Abstract][Full Text] [Related]
20. Noggin regulation of bone morphogenetic protein (BMP) 2/7 heterodimer activity in vitro.
Zhu W; Kim J; Cheng C; Rawlins BA; Boachie-Adjei O; Crystal RG; Hidaka C
Bone; 2006 Jul; 39(1):61-71. PubMed ID: 16488673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
